BeyondSpring BYSI
NASDAQ BYSI
$0.77 +0.16 (+25.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Other Non-Current Assets (2016 - 2026)

BeyondSpring's (BYSI) quarterly Other Non-Current Assets came in at $4.3 million in Q2 2026, down 72.86% year-over-year from $15.7 million in Q2 2025, and down 19.27% quarter-over-quarter from $5.3 million in Q1 2026.

Analysis

BeyondSpring (BYSI) Other Non-Current Assets (2016 - 2026) Analysis & Trends

BeyondSpring has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $4.3 million for Q2 2026.

  • In Q2 2026, Other Non-Current Assets fell 72.86% year-over-year to $4.3 million; the TTM figure through Jun 2026 stood at $4.3 million (down 72.86% YoY), while the FY2025 annual figure was $8.0 million, down 68.35% from the prior year.
  • Other Non-Current Assets came in at $4.3 million for Q2 2026 at BeyondSpring, down from $5.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $25.3 million in Q4 2024 to a low of $114000.0 in Q2 2022.
  • Average Other Non-Current Assets over 5 years is $8.3 million, with a median of $5.3 million recorded in 2023.
  • Year-over-year, Other Non-Current Assets sank 91.83% in 2022 and surged 3462.81% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $347000.0 in 2022, then surged by 1404.03% to $5.2 million in 2023, then soared by 385.67% to $25.3 million in 2024, then sank by 68.35% to $8.0 million in 2025, then tumbled by 46.84% to $4.3 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $4.3 million in Q2 2026, $5.3 million in Q1 2026, and $8.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 14.27 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 10.73 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 5.93 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 9.94 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 5.50 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 42.45 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 86.76 Mn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 239.50 Mn
10 BeyondSpring 31.51 Mn 31.51 Mn - 4.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.27 Mn
Mar 31, 2026 5.28 Mn
Dec 31, 2025 8.02 Mn
Sep 30, 2025 11.41 Mn
Jun 30, 2025 15.71 Mn
Mar 31, 2025 22.63 Mn
Dec 31, 2024 25.35 Mn
Jun 30, 2024 441,000.00
Dec 31, 2023 5.22 Mn
Jun 30, 2023 341,000.00
Dec 31, 2022 347,000.00
Jun 30, 2022 114,000.00
Dec 31, 2021 3.12 Mn
Sep 30, 2021 1.37 Mn
Jun 30, 2021 1.40 Mn
Mar 31, 2021 1.30 Mn
Dec 31, 2020 1.28 Mn
Sep 30, 2020 1.18 Mn
Jun 30, 2020 1.09 Mn
Mar 31, 2020 941,000.00